[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AlphaSenseInc Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1858388203.png) AlphaSense [@AlphaSenseInc](/creator/twitter/AlphaSenseInc) on x 24.7K followers
Created: 2025-07-16 15:36:43 UTC

$JNJ reported strong Q2 2025 results with operational sales growth of 4.6%, driven by robust performance across both Innovative Medicine and MedTech segments despite STELARA loss of exclusivity. The company raised full-year guidance and highlighted significant progress in oncology, immunology, and cardiovascular portfolios.

Key Financial Results:
- Worldwide sales of $XXXX billion, with operational growth of XXX%

- U.S. growth of XXX% and XXX% outside the U.S.

- Net earnings of $XXX billion with diluted EPS of $XXXX vs $XXXX year ago

- Adjusted diluted EPS of $2.77, representing a decrease of XXX% compared to Q2 2024

Macroeconomic Environment:
- Impact of tariffs expected to be approximately $XXX million in 2025

- Company monitoring future years' impact from tariffs

- Commitment to invest $XX billion in U.S. manufacturing over next X years

Financial Guidance and Outlook:
- Raised full year sales guidance by $X billion and EPS guidance by $XXXX to $10.60-$10.85

- Expecting operational sales growth of XXX% to X% for full year

- Anticipating reported sales growth between XXX% to XXX%

- Projecting net interest expense between $X and $XXX million

![](https://pbs.twimg.com/media/Gv_VG7-XMAADRss.png)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945507900161659218/c:line.svg)

**Related Topics**
[jnj](/topic/jnj)
[medtech](/topic/medtech)
[$jnj](/topic/$jnj)
[johnson johnson](/topic/johnson-johnson)
[stocks healthcare](/topic/stocks-healthcare)
[$issc](/topic/$issc)

[Post Link](https://x.com/AlphaSenseInc/status/1945507900161659218)